ExploreInterventionPrenatal methamphetamine exposure
Intervention

Prenatal methamphetamine exposure

Also known as: Prenatal methamphetamine exposure (any use during pregnancy, confirmed by self-report and/or meconium GC/MS) MA
12 findings 1 paper 10 related entities View in graph →

Related entities

conditions
outcomes
populations
studys

Findings (50)

None
decline

Prenatal methamphetamine exposure was associated with a 3-fold increased likelihood of scoring greater than 50% on the ADHD Confidence Index at age 5.5 years after adjusting for covariates, indicating

Effect: decline; OR 3.1; CI: 95% CI 1.2–7.8

Size: OR 3.1 CI: 95% CI 1.2–7.8
None
decline

Prenatal methamphetamine exposure was associated with a 3-fold increased likelihood of scoring greater than 50% on the ADHD Confidence Index at age 5.5 years after adjusting for covariates, indicating

Effect: decline; OR 3.1; CI: 95% CI 1.2–7.8

Size: OR 3.1 CI: 95% CI 1.2–7.8
None
decline

Prenatal methamphetamine exposure was associated with a 3-fold increased likelihood of scoring greater than 50% on the ADHD Confidence Index at age 5.5 years after adjusting for covariates, indicating

Effect: decline; OR 3.1; CI: 95% CI 1.2–7.8

Size: OR 3.1 CI: 95% CI 1.2–7.8
None
decline

Prenatal methamphetamine exposure was associated with a 3-fold increased likelihood of scoring greater than 50% on the ADHD Confidence Index at age 5.5 years after adjusting for covariates, indicating

Effect: decline; OR 3.1; CI: 95% CI 1.2–7.8

Size: OR 3.1 CI: 95% CI 1.2–7.8
None
decline

Prenatal methamphetamine exposure was associated with a 3-fold increased likelihood of scoring greater than 50% on the ADHD Confidence Index at age 5.5 years after adjusting for covariates, indicating

Effect: decline; OR 3.1; CI: 95% CI 1.2–7.8

Size: OR 3.1 CI: 95% CI 1.2–7.8
None
decline

Prenatal methamphetamine exposure was associated with a 3-fold increased likelihood of scoring greater than 50% on the ADHD Confidence Index at age 5.5 years after adjusting for covariates, indicating

Effect: decline; OR 3.1; CI: 95% CI 1.2–7.8

Size: OR 3.1 CI: 95% CI 1.2–7.8
None
decline

Prenatal methamphetamine exposure was associated with a 3-fold increased likelihood of scoring greater than 50% on the ADHD Confidence Index at age 5.5 years after adjusting for covariates, indicating

Effect: decline; OR 3.1; CI: 95% CI 1.2–7.8

Size: OR 3.1 CI: 95% CI 1.2–7.8
None
decline

Prenatal methamphetamine exposure was associated with a 3-fold increased likelihood of scoring greater than 50% on the ADHD Confidence Index at age 5.5 years after adjusting for covariates, indicating

Effect: decline; OR 3.1; CI: 95% CI 1.2–7.8

Size: OR 3.1 CI: 95% CI 1.2–7.8
None
decline

Prenatal methamphetamine exposure was associated with a 3-fold increased likelihood of scoring greater than 50% on the ADHD Confidence Index at age 5.5 years after adjusting for covariates, indicating

Effect: decline; OR 3.1; CI: 95% CI 1.2–7.8

Size: OR 3.1 CI: 95% CI 1.2–7.8
None
decline

Prenatal methamphetamine exposure was associated with a 3-fold increased likelihood of scoring greater than 50% on the ADHD Confidence Index at age 5.5 years after adjusting for covariates, indicating

Effect: decline; OR 3.1; CI: 95% CI 1.2–7.8

Size: OR 3.1 CI: 95% CI 1.2–7.8
None
decline

Prenatal methamphetamine exposure was associated with a 3-fold increased likelihood of scoring greater than 50% on the ADHD Confidence Index at age 5.5 years after adjusting for covariates, indicating

Effect: decline; OR 3.1; CI: 95% CI 1.2–7.8

Size: OR 3.1 CI: 95% CI 1.2–7.8
None
decline

Prenatal methamphetamine exposure was associated with a 3-fold increased likelihood of scoring greater than 50% on the ADHD Confidence Index at age 5.5 years after adjusting for covariates, indicating

Effect: decline; OR 3.1; CI: 95% CI 1.2–7.8

Size: OR 3.1 CI: 95% CI 1.2–7.8
None
decline

Prenatal methamphetamine exposure was associated with a 3-fold increased likelihood of scoring greater than 50% on the ADHD Confidence Index at age 5.5 years after adjusting for covariates, indicating

Effect: decline; OR 3.1; CI: 95% CI 1.2–7.8

Size: OR 3.1 CI: 95% CI 1.2–7.8
None
decline

Prenatal methamphetamine exposure was associated with a 3-fold increased likelihood of scoring greater than 50% on the ADHD Confidence Index at age 5.5 years after adjusting for covariates, indicating

Effect: decline; OR 3.1; CI: 95% CI 1.2–7.8

Size: OR 3.1 CI: 95% CI 1.2–7.8
None
decline

Prenatal methamphetamine exposure was associated with a 3-fold increased likelihood of scoring greater than 50% on the ADHD Confidence Index at age 5.5 years after adjusting for covariates, indicating

Effect: decline; OR 3.1; CI: 95% CI 1.2–7.8

Size: OR 3.1 CI: 95% CI 1.2–7.8
None
decline

Prenatal methamphetamine exposure was associated with a 3-fold increased likelihood of scoring greater than 50% on the ADHD Confidence Index at age 5.5 years after adjusting for covariates, indicating

Effect: decline; OR 3.1; CI: 95% CI 1.2–7.8

Size: OR 3.1 CI: 95% CI 1.2–7.8
None
decline

Prenatal methamphetamine exposure was associated with a 3-fold increased likelihood of scoring greater than 50% on the ADHD Confidence Index at age 5.5 years after adjusting for covariates, indicating

Effect: decline; OR 3.1; CI: 95% CI 1.2–7.8

Size: OR 3.1 CI: 95% CI 1.2–7.8
None
decline

Prenatal methamphetamine exposure was associated with a 3-fold increased likelihood of scoring greater than 50% on the ADHD Confidence Index at age 5.5 years after adjusting for covariates, indicating

Effect: decline; OR 3.1; CI: 95% CI 1.2–7.8

Size: OR 3.1 CI: 95% CI 1.2–7.8
None
decline

Prenatal methamphetamine exposure was associated with a 3-fold increased likelihood of scoring greater than 50% on the ADHD Confidence Index at age 5.5 years after adjusting for covariates, indicating

Effect: decline; OR 3.1; CI: 95% CI 1.2–7.8

Size: OR 3.1 CI: 95% CI 1.2–7.8
None
decline

Prenatal methamphetamine exposure was associated with a 3-fold increased likelihood of scoring greater than 50% on the ADHD Confidence Index at age 5.5 years after adjusting for covariates, indicating

Effect: decline; OR 3.1; CI: 95% CI 1.2–7.8

Size: OR 3.1 CI: 95% CI 1.2–7.8
None
decline

Prenatal methamphetamine exposure was associated with a 3-fold increased likelihood of scoring greater than 50% on the ADHD Confidence Index at age 5.5 years after adjusting for covariates, indicating

Effect: decline; OR 3.1; CI: 95% CI 1.2–7.8

Size: OR 3.1 CI: 95% CI 1.2–7.8
None
decline

Prenatal methamphetamine exposure was associated with a 3-fold increased likelihood of scoring greater than 50% on the ADHD Confidence Index at age 5.5 years after adjusting for covariates, indicating

Effect: decline; OR 3.1; CI: 95% CI 1.2–7.8

Size: OR 3.1 CI: 95% CI 1.2–7.8
None
decline

Prenatal methamphetamine exposure was associated with a 3-fold increased likelihood of scoring greater than 50% on the ADHD Confidence Index at age 5.5 years after adjusting for covariates, indicating

Effect: decline; OR 3.1; CI: 95% CI 1.2–7.8

Size: OR 3.1 CI: 95% CI 1.2–7.8
None
decline

Prenatal methamphetamine exposure was associated with a 3-fold increased likelihood of scoring greater than 50% on the ADHD Confidence Index at age 5.5 years after adjusting for covariates, indicating

Effect: decline; OR 3.1; CI: 95% CI 1.2–7.8

Size: OR 3.1 CI: 95% CI 1.2–7.8
None
decline

Prenatal methamphetamine exposure was associated with a 3-fold increased likelihood of scoring greater than 50% on the ADHD Confidence Index at age 5.5 years after adjusting for covariates, indicating

Effect: decline; OR 3.1; CI: 95% CI 1.2–7.8

Size: OR 3.1 CI: 95% CI 1.2–7.8
None
decline

Prenatal methamphetamine exposure was associated with a 3-fold increased likelihood of scoring greater than 50% on the ADHD Confidence Index at age 5.5 years after adjusting for covariates, indicating

Effect: decline; OR 3.1; CI: 95% CI 1.2–7.8

Size: OR 3.1 CI: 95% CI 1.2–7.8
None
decline

Prenatal methamphetamine exposure was associated with a 3-fold increased likelihood of scoring greater than 50% on the ADHD Confidence Index at age 5.5 years after adjusting for covariates, indicating

Effect: decline; OR 3.1; CI: 95% CI 1.2–7.8

Size: OR 3.1 CI: 95% CI 1.2–7.8
None
decline

Prenatal methamphetamine exposure was associated with increased slope of reaction time across blocks on the K-CPT, indicating greater vigilance decline as the test progressed, consistent with attentio

Effect: decline

None
decline

Prenatal methamphetamine exposure was associated with increased slope of reaction time across blocks on the K-CPT, indicating greater vigilance decline as the test progressed, consistent with attentio

Effect: decline

None
decline

Prenatal methamphetamine exposure was associated with increased slope of reaction time across blocks on the K-CPT, indicating greater vigilance decline as the test progressed, consistent with attentio

Effect: decline

None
null

Prenatal methamphetamine exposure was not associated with differences in errors of omission, commission, overall hit reaction time, or perseverations on the K-CPT at age 5.5 years after adjusting for

Effect: null

None
null

Prenatal methamphetamine exposure was not associated with differences in errors of omission, commission, overall hit reaction time, or perseverations on the K-CPT at age 5.5 years after adjusting for

Effect: null

None
null

Prenatal methamphetamine exposure was not associated with differences in errors of omission, commission, overall hit reaction time, or perseverations on the K-CPT at age 5.5 years after adjusting for

Effect: null

None
null

Prenatal methamphetamine exposure was not associated with differences in errors of omission, commission, overall hit reaction time, or perseverations on the K-CPT at age 5.5 years after adjusting for

Effect: null

None
null

Prenatal methamphetamine exposure was not associated with differences in errors of omission, commission, overall hit reaction time, or perseverations on the K-CPT at age 5.5 years after adjusting for

Effect: null

None
null

Prenatal methamphetamine exposure was not associated with differences in errors of omission, commission, overall hit reaction time, or perseverations on the K-CPT at age 5.5 years after adjusting for

Effect: null

None
null

Prenatal methamphetamine exposure was not associated with differences in errors of omission, commission, overall hit reaction time, or perseverations on the K-CPT at age 5.5 years after adjusting for

Effect: null

None
null

Prenatal methamphetamine exposure was not associated with differences in errors of omission, commission, overall hit reaction time, or perseverations on the K-CPT at age 5.5 years after adjusting for

Effect: null

None
null

Prenatal methamphetamine exposure was not associated with differences in errors of omission, commission, overall hit reaction time, or perseverations on the K-CPT at age 5.5 years after adjusting for

Effect: null

None
null

Prenatal methamphetamine exposure was not associated with differences in errors of omission, commission, overall hit reaction time, or perseverations on the K-CPT at age 5.5 years after adjusting for

Effect: null

None
null

Prenatal methamphetamine exposure was not associated with differences in errors of omission, commission, overall hit reaction time, or perseverations on the K-CPT at age 5.5 years after adjusting for

Effect: null

None
null

Prenatal methamphetamine exposure was not associated with differences in errors of omission, commission, overall hit reaction time, or perseverations on the K-CPT at age 5.5 years after adjusting for

Effect: null

None
null

Prenatal methamphetamine exposure was not associated with differences in errors of omission, commission, overall hit reaction time, or perseverations on the K-CPT at age 5.5 years after adjusting for

Effect: null

None
null

Prenatal methamphetamine exposure was not associated with differences in errors of omission, commission, overall hit reaction time, or perseverations on the K-CPT at age 5.5 years after adjusting for

Effect: null

None
null

Prenatal methamphetamine exposure was not associated with differences in errors of omission, commission, overall hit reaction time, or perseverations on the K-CPT at age 5.5 years after adjusting for

Effect: null

None
null

Prenatal methamphetamine exposure was not associated with differences in errors of omission, commission, overall hit reaction time, or perseverations on the K-CPT at age 5.5 years after adjusting for

Effect: null

None
null

Prenatal methamphetamine exposure was not associated with differences in errors of omission, commission, overall hit reaction time, or perseverations on the K-CPT at age 5.5 years after adjusting for

Effect: null

None
null

Prenatal methamphetamine exposure was not associated with differences in errors of omission, commission, overall hit reaction time, or perseverations on the K-CPT at age 5.5 years after adjusting for

Effect: null

None
decline

Prenatal methamphetamine exposure was associated with increased variability in reaction time with longer interstimulus intervals on the K-CPT, indicating less consistent attention when the child has t

Effect: decline

None
decline

Prenatal methamphetamine exposure was associated with increased variability in reaction time with longer interstimulus intervals on the K-CPT, indicating less consistent attention when the child has t

Effect: decline

Papers (1)